Breath-Based Diagnostic

About Varro

Varro Life Sciences is an innovative diagnostics company building a rapid, non-invasive pathogen detection platform centered on its proprietary Micro Immunoelectrodes (MIEs). The technology uses nanobody-based electrochemical biosensors to identify pathogens in breath or air with high specificity, targeting applications in public health, agriculture, transportation, and built environments. Backed by a $42.5 million investment and led by a seasoned team with biotech and financial markets expertise, Varro is advancing its product portfolio and expanding its operations to commercialize its ultrafast, low-cost detection solutions.

Therapeutic Areas